Wenyu Zou

Endocrine adverse events related to immune checkpoint inhibitors in gastric cancer

This study aimed to systematically assess the endocrine adverse reactions associated with Immune checkpoint inhibitors (ICIs) in the treatment of gastric cancer. Data from the FDA Adverse Event Reporting System (FAERS) spanning from Q1 2013 to Q3 2024 were analyzed. The associati...